yahoo_financeOriginal article
Mesoblast shares jump as Phase 3 chronic back pain trial completes patient treatment
Phase 3Positive
AI Analysis
Summary
Mesoblast announced completion of patient treatment in a Phase 3 trial for chronic back pain, resulting in a positive share price movement. The trial has finished enrolling and treating patients, marking a significant milestone in the clinical development program.
Clinical Trial Data
Phase
Phase 3
Outcome Details
Phase 3 trial completed patient treatment enrollment
Importance:6/10
Sentiment:
0.60
Phase 3chronic back paintrial completionclinical development
Related Companies
Read the original article
Published by yahoo_finance on August 17, 2026 2:09 PM